Research | Division of Oncology
cincinnatichildrens.org shows its articles on its own site.
Read the article on cincinnatichildrens.org ↗Article · Nov 2026 · 1 min read
In brief
In brief
The Oncology Division focuses on accelerating the development of novel therapeutics for pediatric cancer patients. Their research program aims to translate laboratory discoveries into clinical applications that improve outcomes for children with malignancies.
Written by the GCMD Library team from the article.
The Oncology Division aims to speed up the development of new drugs and therapies for children with cancer. Get more information on our work.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
Publications
Joseph G. Pressey · Published Nov 2026
Article
Research
Joseph G. Pressey · Published Nov 2026
Article
Embryonal rhabdomyosarcoma with a novel t(2;6)(p23;p21.1).
Joseph G. Pressey · Published Nov 2026
Article
Newsroom
Alessandro de Alarcon · Published Oct 2026
Article
Support Services | Cincinnati Children's Research Foundation
Alessandro de Alarcon · Published Oct 2026
Article
Researchers, Cincinnati Children's Hospital Medical Center
Alessandro de Alarcon · Published Oct 2026
Article
Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients.
Joseph G. Pressey · Published Nov 2026
Article
Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
Joseph G. Pressey · Published Nov 2026
Article
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.
Joseph G. Pressey · Published Nov 2026
Article
Using cancer phenotype sex-specificity to enable unbiased penetrance estimation of SMARCA4 pathogenic variants for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Joseph G. Pressey · Published Nov 2026
Article
MR Imaging of Pediatric Musculoskeletal Tumors:: Recent Advances and Clinical Applications.
Joseph G. Pressey · Published Nov 2026
Article
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.
Joseph G. Pressey · Published Nov 2026